Suppr超能文献

饮食与肠道微生物的相互作用影响癌症免疫疗法。

Diet-gut microbial interactions influence cancer immunotherapy.

作者信息

Wang Xue, Geng Shitao

机构信息

Department of Oncology, First People's Hospital of Guangyuan, Guangyuan, China.

Department of Emergency, First Naval Hospital of Southern Theater Command, Zhanjiang, China.

出版信息

Front Oncol. 2023 Mar 24;13:1138362. doi: 10.3389/fonc.2023.1138362. eCollection 2023.

Abstract

The gut microbiome is involved in the absorption and metabolism of host nutrients and modulates the immune response, affecting the efficacy of immunotherapy for cancer. In patients receiving immunotherapy, appropriate modifications of gut microbiota are thought to improve therapeutic response. Of all the factors that influence the gut microbiota, diet is the most influential and modifiable. Healthy dietary patterns as well as some specific dietary components can help the growth of beneficial microbiota in the gut, thereby protecting against cancers and promoting human health. A growing number of researches have confirmed the positive effects of a diet-gut microbiota approach as an adjuvant therapy for cancer, but controversy remains. Here, we summarize the interactions between diet and gut microbes based on previous studies, and discuss the role of gut microbiota-based dietary strategies in tumor immunotherapy, with the potential mechanisms of actions also intensively discussed.

摘要

肠道微生物群参与宿主营养物质的吸收和代谢,并调节免疫反应,影响癌症免疫治疗的疗效。在接受免疫治疗的患者中,适当改变肠道微生物群被认为可以改善治疗反应。在所有影响肠道微生物群的因素中,饮食是最具影响力且可改变的。健康的饮食模式以及一些特定的饮食成分有助于肠道中有益微生物群的生长,从而预防癌症并促进人类健康。越来越多的研究证实了饮食-肠道微生物群方法作为癌症辅助治疗的积极作用,但仍存在争议。在此,我们基于先前的研究总结饮食与肠道微生物之间的相互作用,并讨论基于肠道微生物群的饮食策略在肿瘤免疫治疗中的作用,同时也深入探讨其潜在作用机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41aa/10081683/059cd167937e/fonc-13-1138362-g001.jpg

相似文献

1
Diet-gut microbial interactions influence cancer immunotherapy.
Front Oncol. 2023 Mar 24;13:1138362. doi: 10.3389/fonc.2023.1138362. eCollection 2023.
2
Targeting gut microbiota with dietary components on cancer: Effects and potential mechanisms of action.
Crit Rev Food Sci Nutr. 2020;60(6):1025-1037. doi: 10.1080/10408398.2018.1555789. Epub 2019 Jan 11.
3
Effects of gut microbiota on immune responses and immunotherapy in colorectal cancer.
Front Immunol. 2022 Nov 8;13:1030745. doi: 10.3389/fimmu.2022.1030745. eCollection 2022.
4
Targeting the Gut Microbiome to Improve Immunotherapy Outcomes: A Review.
Integr Cancer Ther. 2024 Jan-Dec;23:15347354241269870. doi: 10.1177/15347354241269870.
5
Gut microbiome in multiple myeloma: Mechanisms of progression and clinical applications.
Front Immunol. 2022 Dec 8;13:1058272. doi: 10.3389/fimmu.2022.1058272. eCollection 2022.
6
Gut Microbiota, in the Halfway between Nutrition and Lung Function.
Nutrients. 2021 May 19;13(5):1716. doi: 10.3390/nu13051716.
7
The role of the gut microbiome in modulating immunotherapy efficacy in colorectal cancer.
IUBMB Life. 2024 Dec;76(12):1050-1057. doi: 10.1002/iub.2908. Epub 2024 Aug 12.
9
Hepatocellular Carcinoma Immunotherapy and the Potential Influence of Gut Microbiome.
Int J Mol Sci. 2021 Jul 21;22(15):7800. doi: 10.3390/ijms22157800.
10
Chewing the Fat with Microbes: Lipid Crosstalk in the Gut.
Nutrients. 2022 Jan 28;14(3):573. doi: 10.3390/nu14030573.

引用本文的文献

1
Modulating tumor immunity using advanced microbiome therapeutics producing an indole metabolite.
EMBO Rep. 2025 Apr;26(7):1688-1708. doi: 10.1038/s44319-025-00386-9. Epub 2025 Mar 7.
2
Ketogenic diet and cancer: multidimensional exploration and research.
Sci China Life Sci. 2025 Apr;68(4):1010-1024. doi: 10.1007/s11427-023-2637-2. Epub 2025 Jan 14.
3
IRnet: Immunotherapy response prediction using pathway knowledge-informed graph neural network.
J Adv Res. 2025 Jun;72:319-331. doi: 10.1016/j.jare.2024.07.036. Epub 2024 Aug 7.
4
An exploratory study of a multi-species probiotic formulation and markers of health in a real-world oncological cohort in the time of covid.
Inflammopharmacology. 2024 Aug;32(4):2317-2335. doi: 10.1007/s10787-024-01503-1. Epub 2024 Jun 26.
5
Mechanism-guided fine-tuned microbiome potentiates anti-tumor immunity in HCC.
Front Immunol. 2023 Dec 19;14:1333864. doi: 10.3389/fimmu.2023.1333864. eCollection 2023.
6
Circadian lifestyle determinants of immune checkpoint inhibitor efficacy.
Front Oncol. 2023 Dec 4;13:1284089. doi: 10.3389/fonc.2023.1284089. eCollection 2023.

本文引用的文献

1
Interactions between and the resident microbiota.
Front Microbiol. 2022 Sep 20;13:930495. doi: 10.3389/fmicb.2022.930495. eCollection 2022.
3
Western-Style Diet, pks Island-Carrying Escherichia coli, and Colorectal Cancer: Analyses From Two Large Prospective Cohort Studies.
Gastroenterology. 2022 Oct;163(4):862-874. doi: 10.1053/j.gastro.2022.06.054. Epub 2022 Jun 24.
4
Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies.
J Hematol Oncol. 2022 Apr 29;15(1):47. doi: 10.1186/s13045-022-01273-9.
5
Targeting the gut and tumor microbiota in cancer.
Nat Med. 2022 Apr;28(4):690-703. doi: 10.1038/s41591-022-01779-2. Epub 2022 Apr 19.
6
Human gut bacteria produce Τ17-modulating bile acid metabolites.
Nature. 2022 Mar;603(7903):907-912. doi: 10.1038/s41586-022-04480-z. Epub 2022 Mar 16.
7
Dietary Lactobacillus-Derived Exopolysaccharide Enhances Immune-Checkpoint Blockade Therapy.
Cancer Discov. 2022 May 2;12(5):1336-1355. doi: 10.1158/2159-8290.CD-21-0929.
8
Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response.
Science. 2021 Dec 24;374(6575):1632-1640. doi: 10.1126/science.aaz7015. Epub 2021 Dec 23.
9
Gut microbiota-derived short-chain fatty acids and colorectal cancer: Ready for clinical translation?
Cancer Lett. 2022 Feb 1;526:225-235. doi: 10.1016/j.canlet.2021.11.027. Epub 2021 Nov 26.
10
Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment.
Cell. 2021 Oct 14;184(21):5338-5356.e21. doi: 10.1016/j.cell.2021.09.019. Epub 2021 Oct 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验